Malignant lymphoma of the testis

Area of Science:

• Oncology
• Hematology
• Urologic Oncology

Background:

• Malignant lymphomas represent approximately 5% of testicular neoplasms.
• Testicular lymphoma is the most frequent testicular malignancy in patients aged 60-80.
• This condition often presents with extranodal involvement, including skin, CNS, and Waldeyer's ring.

Purpose of the Study:

• To describe the characteristics and recommended treatment for testicular lymphoma.
• To highlight the association of testicular lymphoma with other sites.
• To emphasize the aggressive nature and poor-risk classification of this malignancy.

Main Methods:

• Review of existing literature on testicular lymphoma.
• Analysis of common histologic subtypes and patient demographics.
• Discussion of treatment strategies based on current standards of care.

Main Results:

• Diffuse histiocytic lymphoma is the most common histologic subtype.
• Patients are generally classified as having poor-risk non-Hodgkin's lymphoma.
• Associated extranodal sites include skin, CNS, Waldeyer's ring, and contralateral testicle.

Conclusions:

• Testicular lymphoma requires aggressive management due to its poor-risk profile.
• Combination chemotherapy, potentially with radiotherapy, is the recommended treatment approach.
• Early recognition and comprehensive treatment are crucial for managing testicular lymphoma.